Navigation Links
HeartWare Selects Allen & Caron for Investor Relations and Corporate Communications
Date:3/24/2008

re (ASX: HTW) develops and manufactures miniaturized implantable heart pumps, or Left Ventricular Assist Devices ("LVADs"), to treat patients suffering from advanced heart failure. The Company is developing the industry's smallest and least invasive pumps, which it believes will be the key to unlocking the potential of a large and underserved market. The HeartWare(R) LVAD is the only full-output pump designed to be implanted in the chest, avoiding the abdominal surgery generally required to implant competing devices. The device is currently the subject of an international clinical trial involving five investigational centers in Europe and Australia. A clinical trial in the U.S. is expected to begin in the first half of 2008.

About Allen & Caron

Allen & Caron is a full-service corporate, investor and marketing communications agency serving the needs of public companies. The Allen & Caron international client base includes emerging growth companies in a range of industry segments. The firm has offices in Irvine, California; New York City and London; maintains representation in Paris; and has an affiliate relationship with a leading investor relations firm in Italy, with offices in Milan and Rome.

For further information:

http://www.heartware.com.au US Investor Relations

Howard Leibman Matt Clawson

Director Corporate Development Partner

HeartWare Limited Allen & Caron Inc

Email: howard.leibman@heartware.com.au Email: matt@allencaron.com

Tel: +61 2 9238 2064 Tel: +1 949 474 4300


'/>"/>
SOURCE Allen & Caron Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Wheelchair Professionals Selects Authentidates Inscrybe Healthcare Platform to Streamline Mobility Order Processing
2. Hawaiis Premier Physician Management Company, TeamPraxis, Selects Allscripts Electronic Health Record for Statewide Deployment
3. Antares Management Solutions Selects Hyland Softwares OnBase
4. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
5. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
6. Civista Health Inc. Selects Phoenix Health Systems for Information Technology Outsourcing Services
7. DFW Partnership for Peak Health Care Performance Selects Data Aggregator for Diabetes Treatment Program
8. KISTI Selects ANSYS as a Key Supplier in Engineering Simulation
9. Non-Resident Fathers Project Selects Four National Sites for Funding to Increase Father Involvement and Improve Outcomes in Child Welfare
10. Top Nutritional Supplement Online Retailer, iHerb.com, Selects AlertSite for Web Site Performance Monitoring
11. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...SHINGTON, Nov. 8 The fo...tor, Operation Rescue Insurrecta Nex. ,, Mr. T...ve been fighting to keep child-killing by abortion... Terry states: "This is a great first step to vict...have a lot of fighting ahead of us. Our rejoicing ...
(Date:11/8/2009)...LLYWOOD, Calif., Nov. 8 ...on of Babies luncheon to recognize prominent indiv...dren and who are role models for March of Dimes co... of the March of Dimes November Prematurity Awaren... were urged to join the fight for preemies! ,, ...
(Date:11/7/2009)...USTON, Nov. 7 The Ameri...sa James, Director of Health at the Family Violenc...shed Service today at its semi-annual policy-makin... is the highest honor the AMA House of Delegates b...//www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ...
(Date:11/7/2009)...SHINGTON, Nov. 7 With t...antichoice extremists are holding the entire bill ... are demanding that the bill go far beyond the sta...orporated into the original bill. In an outrageou...y Saturday afternoon, antichoice Democrats are dem...
(Date:11/7/2009)...ON, Nov. 7 Americans United for Life Action endor...pak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smi... money from going to abortion in health care refor... and CEO Dr. Charmaine Yoest said, "Americans Unit...lsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Ame...
Breaking Medicine News(10 mins):Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...rchers at the Monash Institute of Medical Research...nfrared spectroscopy, which allowed scientists// t... it was the first of its kind in Australia, helped...esearch (MIMR) are carrying out studies to underst...
...tists at the University of Bristol have recommende...epaired by bioengineered tissue implants //without...e maturation of cartilage implanted with engineere...ered cartilage implanted in injured and osteoarthr...
...ar-old Indian boy, Santosh Baniya whose parents we...e of the stigma associated with the disease//. ...fter he set himself on fire in Ahmedabad last week...urviving his parents as well as being ostracised o...
...ding to a research conducted by Stephanie Chiuve i...educes the risk of heart ailments//. U.S. rese...pressure and cholesterol can benefit if they alter...nking and smoking habits. But it is good news ...
...ew Zealand Winegrowers are affected by the type 3 ...and quality of grapevines//. But most of the w...ine which are tested vines and are free from the v...d ongoing management and detection. Mr Manson said...
...yers in British Columbia (B.C) are bearing the med... the province for health services//. Government o...lem. Health Minister, George Abbott of B.C. ...is prompting health authorities to look at novel w...
Other Medicine News:Health News:Preterm Babies Benefited from a New NI Spectroscopy 2Health News:Engineered Tissue Implants benefited Knee Injured patients 2
(Date:11/7/2009)... BEACH, Fla., Nov. 7 Patients repo... an effective therapy in treating acute swelling a...rious genetic disorder, according to data presente...sthma & Immunology (ACAAI) Annual Meeting. The...nts conducted in parallel with the ongoing, prospe...
(Date:11/6/2009)...LL, Wash., Nov. 6 SCOLR ...l results for the three and nine months ended Sept...harma,s President and CEO, said, "We continue to a...r ibuprofen formulation. Several potential partner...rsonnel and external resources as they evaluate th...
(Date:11/6/2009)...OUIS, Nov. 6 Recession i...depress sales for Allied Healthcare Products in th...er 30, 2009. ,, Sales declines pushed Allied in...uarter was about $745,000, or negative 9 cents per...of about $208,000, or 3 cents per share. ,, Sa...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Discovering soybean plants resistant to aphids and a new aphid 9530 1Discovering soybean plants resistant to aphids and a new aphid 9530 2Discovering soybean plants resistant to aphids and a new aphid 9530 3Discovering soybean plants resistant to aphids and a new aphid 9530 4PLUS Diagnostics Announces Senior Executive Appointments 54089 1PLUS Diagnostics Announces Senior Executive Appointments 54089 2PLUS Diagnostics Announces Senior Executive Appointments 54089 3Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 1Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 2Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 3
... (Zurich), Switzerland, May 24, 2007 - Cytos,Biote... a,placebo-controlled, double-blind combined phase...ndidate for the treatment of,psoriasis and other i...rst-time-in-man clinical trial and included 48 pat...riasis. In a first part,of the study, the safety a...
... Mass.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen,...that develops targeted,anticancer therapeutics usi...oday announced that clinical findings for three,di...umors are to be,reported at the 43rd American Soci...take place June 1-5, 2007 in Chicago, IL., Trastuz...
Other Medicine Technology:Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3
Agarose, ultra high resolution, Molecular Biology Grade
AGAROSE I (Molecular Biology Grade)
Agarose, 500g
Agarose NA
Medicine Products: